The Inflation Reduction Act will protect Medicare recipients from catastrophic drug costs by phasing in a cap for out-of-pocket costs and establishing a$35 cap for a month’s supply of insulin. And, as an historic win, Medicare will be able to negotiate prices for high-cost drugs for the first time ever.
#benefitstower #InflationReductionAct2022 #HealthCare #healthcarecosts #Interests #lifeinsurance #insurancebroker #InsuranceForAll
